Samsung Bioepis and EpisNexLab partner with G2GBio to develop long-acting obesity treatments using microsphere-based drug delivery technology, while Samsung Epis Holdings invests 20 billion won in convertible bonds as part of open innovation strategy to expand into comprehensive bio company.
#YonhapInfomax #SamsungBioepis #ObesityTreatment #G2GBio #DrugDeliveryTechnology #Semaglutide #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=110037
Samsung Bioepis, EpisNexLab Partner with G2GBio to Develop Obesity Treatment
Samsung Bioepis and EpisNexLab partner with G2GBio to develop long-acting obesity treatments using microsphere-based drug delivery technology, while Samsung Epis Holdings invests 20 billion won in convertible bonds as part of open innovation strategy to expand into comprehensive bio company.
South Korea’s IPO market sees G2GBio debut on KOSDAQ this week, with three other firms—Halla Cast, JPI Healthcare, and Graphy—opening retail subscriptions, highlighting robust activity in the pharmaceutical and tech sectors.
#YonhapInfomax #G2GBio #KOSDAQ #IPO #RetailSubscription #Pharmaceuticals #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=76382
G2GBio to Debut on KOSDAQ This Week—Three Companies Including Halla Cast Launch Retail IPO Subscriptions
South Korea’s IPO market sees G2GBio debut on KOSDAQ this week, with three other firms—Halla Cast, JPI Healthcare, and Graphy—opening retail subscriptions, highlighting robust activity in the pharmaceutical and tech sectors.
IT Chem is set to list on KOSDAQ this week, with four companies opening retail IPO subscriptions and four others launching institutional bookbuilding, highlighting robust activity in South Korea’s IPO market.
#YonhapInfomax #ITChem #KOSDAQ #IPO #G2GBio #InstitutionalBookbuilding #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket https://en.infomaxai.com/news/articleView.html?idxno=75290
IT Chem to List on KOSDAQ This Week—Four Companies Open Retail Subscriptions, Four Launch Institutional Bookbuilding
IT Chem is set to list on KOSDAQ this week, with four companies opening retail IPO subscriptions and four others launching institutional bookbuilding, highlighting robust activity in South Korea’s IPO market.
Yonhap Infomax News